NewsRx

Search our medical news database

Finance

Pharma company sales increase 16% in 2005

Published in Obesity and Diabetes Week, February 27th, 2006

Novo Nordisk A/S (NVO) announced sales in 2005 increased by 16% and operating profit grew by 16%, which exceeded previous expectations.

The company reported sales of insulin analogs increased by 62%, sales of NovoSeven increased by 16%, sales in North America increased by 27% and sales in international operations increased by 25%.

Operating profit increased by 16% to US$1,349 million while underlying operating profit (measured in local currencies and excluding nonrecurring items) increased by around 20%. Net profit increased by 17% to US$978 million and earnings per share (diluted) increased by 20% to US$2.97.

The long-term...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook